@adamfeuersteinOct 27, 2025 · 10:36 PM$BMRN tonight said it was divesting Roctavian, its underperforming gene therapy for hemophilia A. $NTLA take note. Time to wind down, return cash to shareholders. Salvage what you can.Open on X →